Voices of Oncology: Fostering a Collaborative Community of Experts to Accelerate Cancer Cures (Paperback) (ISBN-13: 9798887500669)

Vendor: Kirk V. Shepard
Product type: Books
Format: Paperback
$21.99
$21.99
$21.99
Subtotal: $21.99
WR Book House

Voices of Oncology: Fostering a Collaborative Community of Experts to Accelerate Cancer Cures

$21.99

Voices of Oncology: Fostering a Collaborative Community of Experts to Accelerate Cancer Cures

$21.99
Format: Paperback
Description
Description
x
Voices of Oncology is a groundbreaking exploration of the evolving landscape in cancer treatment development. Beyond scientific advancements, the field is being reshaped by societal and cultural forces that are redefining what it takes to bring new therapies to patients.

Through exclusive interviews with leading experts from across oncology, this book captures the complexity of a multidisciplinary approach. Each chapter highlights the challenges and breakthroughs that arise from collaboration between pharmaceutical leaders, academic researchers, patient advocates, and healthcare innovators. Together, these voices underscore a powerful message: only by breaking down silos and sharing insights can we accelerate progress and ultimately, conquer cancer.

To go beyond the book and be a voice in a dynamic collaboration of stakeholders in oncology today, we invite you to join the Oncology Voice Network (OVN), an online community for those committed to transforming oncology through shared knowledge and collective action.

Author: Kirk V. Shepard,Ramin Farhood
ISBN-13: 9798887500669
Publisher: Forbes Books
Language: English
Published: 09/09/2025
Pages: 496
Format: Paperback
Weight: 1.80lbs
Size: 9.00h x 6.10w x 1.70d
By Kirk V. Shepard
By Kirk V. Shepard
x
Dr. KIRK SHEPARD, a board-certified oncologist and hematologist, has led pharmaceutical innovation for over thirty years, including roles at Boehringer Ingelheim, Takeda, and Eisai. Currently CMO at PDS Biotechnology, his expertise spans all phases of drug development and commercialization. In 2015, PharmaVoice named him among the 100 Most Inspiring People in Pharma. He also cofounded the Medical Affairs Professional Society (MAPS) and co-edited Medical Affairs (2024).

Dr. RAMIN FARHOOD, senior VP at SSI Strategy, has over twenty-five years in patient-centric medical strategy. Previously at Novartis, he launched the world's first gene therapy for spinal muscular atrophy. Farhood cofounded the Medical Affairs Professional Society (MAPS) and the Immunoglobulin National Society (IgNS) and cohosts The Emerging Biotech Leader podcast.

Recently Viewed Products